---
title: Type I conventional dendritic cells and CD8<sup>+</sup> T cells predict favorable
  clinical outcome of head and neck squamous cell carcinoma patients
date: '2024-06-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38938577/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240628182110&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Head and neck squamous cell carcinoma (HNSCC) is one of the most common
  tumor entities worldwide, with human papillomavirus (HPV) infection contributing
  to cancer development. Conventional therapies achieve only limited efficiency, especially
  in recurrent or metastatic HNSCC. As the immune landscape decisively impacts the
  survival of patients and treatment efficacy, this study comprehensively investigated
  the immunological tumor microenvironment (TME) and its association with patient
  ...
disable_comments: true
---
Head and neck squamous cell carcinoma (HNSCC) is one of the most common tumor entities worldwide, with human papillomavirus (HPV) infection contributing to cancer development. Conventional therapies achieve only limited efficiency, especially in recurrent or metastatic HNSCC. As the immune landscape decisively impacts the survival of patients and treatment efficacy, this study comprehensively investigated the immunological tumor microenvironment (TME) and its association with patient ...